Assessment of blood ammonia level as a non-invasive predictor for presence of EV and risk of bleeding
A prospective cross sectional study on 150 consecutive patients screening for esophageal varices. Patient groups groups: Group (1): 100 patients with esophageal varices Group (2): 50 chronic liver disease patients with no esophageal varices as a control group. All patients will be subjected to: 1. \- Detailed history-taking 2. \- Full clinical examination 3. \- Laboratory investigations: * Complete blood picture (CBC) * Erythrocyte sedimentation rate (ESR) * Renal function tests * Liver function tests * Prothrombin time and activity * Viral markers (HCV Ab - HBV Ag) * Blood ammonia level. 4. \- Pelviabdominal US: Ultrasound examination of the liver, portal venous system, spleen, kidney and other abdominal organs. 5. \- Upper GITendoscopy: * Varices will be classified according to the Japanese classification 1996, * The Baveno 11 score will be used to differentiate between mild and severe portal hypertensive gastropathy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SCREENING
Masking
NONE
Enrollment
150
Tanta Faculty of Medicine
Tanta, Gharbiah, Egypt
RECRUITINGlevel of serum ammonia in patients with risk factors for bleeding from esophageal varices
estimation of level of serum ammonia in patients with risk factors for bleeding from esophageal varices
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.